publication date: Nov. 4, 2016

In Brief Inova and UVA to Develop a Comprehensive Cancer Center

INOVA HEALTH SYSTEM and the University of Virginia agreed to form a research and education partnership to collaborate on research, medical education, and the recruitment of researchers, scientists and investigators.

The planned affiliation includes:

A cancer research partnership between the Inova Schar Cancer Institute and UVA Cancer Center, including efforts to achieve NCI designation as a comprehensive cancer center. A research partnership to develop the Global Genomics and Bioinformatics Research Institute located at the Inova Center for Personalized Health. The institute will recruit researchers, scientists and investigators who will engage in collaborative research focused on genomics, functional biology, bioinformatics, biologically driven engineering, precision medicine, translational research, developmen of targeted therapeutics, and commercialization of new discoveries. A regional campus of the UVA School of Medicine at Inova, which would enable UVA medical students to complete their clerkship and post-clerkship education in Northern Virginia at Inova facilities, with an opportunity for a differentiated medical education experience during the post-clerkship phase. UVA and Inova will explore the creation of a biomedical investment vehicle to advance discovery through to commercialization.

The two institutions said they expect to finalize a definitive agreement later this year.

The Virginia General Assembly contributed $28 million in funding for the partnership in its fiscal 2017-2018 budget. Inova committed another $56 million, and UVA $28 … Continue reading Inova and UVA to Develop a Comprehensive Cancer Center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.